ÂÜÀòÂÒÂ×

Benno Schindelholz is a seasoned professional in the pharmaceutical industry, currently serving as Senior Director, Project Leader, and Alliance Director at Idorsia Pharmaceuticals Ltd since June 2017. With extensive experience spanning over two decades, Schindelholz has successfully led multiple preclinical and clinical development projects, contributing to New Drug Application filings and the integration of Vaxxilon GmbH into Idorsia. Prior to Idorsia, Schindelholz held key roles at Actelion, where strategies for drug development and collaborations with partners were driven, and at The Genetics Company, where leadership encompassed Alzheimer's therapeutics and drug discovery technologies. Academic credentials include a PhD in Neuroscience from the University of Bern and a Master's degree in Biochemistry from ETH Zürich.